Skip to search formSkip to main contentSkip to account menu

nicainoprol

Known as: 1,2,3,4-tetrahydro-8-(2-hydroxy-3-(isopropylamino)propoxy)-1-nicotinoylquinoline 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
The antiarrhythmic and direct cardiovascular effects of a new antiarrhythmic agent, TYB-3823 [1− (2,6-dimethylphenyl)-4,4… 
1989
1989
Using two-stage coronary ligation-, digitalis- and adrenaline-induced canine ventricular arrhythmias, antiarrhythmic effects of… 
1989
1989
We examined the effects of nicainoprol (1-50 microM), a new antiarrhythmic agent, on the transmembrane action potentials in… 
1989
1989
SummaryFrequency- and voltage-dependent effects of a class I antiarrhythmic agent (nicainoprol) on the maximal upstroke velocity… 
1989
1989
SummaryWe investigated the influence of the angiotensin-converting enzyme (ACE) inhibitor ramipril on cardiac arrhythmias in… 
1989
1989
Two-stage coronary ligation-, digitalis-, and epinephrine (EPI)-induced ventricular arrhythmias were used to establish minimum… 
1988
1987
1987
Kinetics and resting and exercise‐induced hemodynamic and ECG effects of nicainoprol, a new antiarrhythmic structurally… 
1986
1986
Summary: The electrophysiological effects of nicainoprol, a new antiarrhythmic drug, were evaluated in a heterogeneous group of…